July 31, 2026

Castle Biosciences, Inc. (CSTL) Stock Analysis: Unpacking a 59.68% Potential Upside in the Healthcare Sector

Castle Biosciences, Inc. (NASDAQ: CSTL), a promising player in the healthcare sector, is making waves with its focus on molecular diagnostics for dermatologic cancers and other serious conditions. With a..

Orthofix Medical Inc. (OFIX) Stock Analysis: A Promising 31.47% Upside in the Healthcare Sector

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the medical devices industry, presents an intriguing investment opportunity for those interested in the healthcare sector. With a market capitalization of..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Exploring a Potential 455% Upside in the Biotech Sector

LENZ Therapeutics, Inc. (NASDAQ: LENZ), a burgeoning player in the biotechnology sector, is capturing attention with its intriguing focus on vision improvement therapies. For investors looking at the healthcare landscape,..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Why Investors Eye a 48.97% Upside Potential

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a prominent player in the healthcare sector, specializes in the development and commercialization of innovative pain management solutions. With a market cap of $1.17 billion,..

Simulations Plus, Inc. (SLP) Stock Analysis: Navigating the Healthcare Tech Landscape with a Modest Growth Potential

For investors keen on the intersection of healthcare and technology, Simulations Plus, Inc. (NASDAQ: SLP) presents a unique proposition. Operating within the healthcare sector, specifically the health information services industry,..

Butterfly Network, Inc. (BFLY) Stock Analysis: Navigating a 25% Revenue Growth in the Healthcare Sector

Butterfly Network, Inc. (BFLY), a trailblazer in the healthcare sector, has been making waves with its innovative handheld ultrasound imaging solutions. As a player in the competitive medical devices industry,..

Arvinas, Inc. (ARVN) Stock Analysis: A Potential 78% Upside for Biotechnology Enthusiasts

Arvinas, Inc. (ARVN), a clinical-stage biotechnology innovator based in New Haven, Connecticut, is capturing the attention of investors with its pioneering approach to tackling disease-causing proteins through targeted protein degraders...

Definitive Healthcare Corp. (DH) Stock Analysis: A 206.79% Potential Upside Beckons Investors

Definitive Healthcare Corp. (NASDAQ: DH) stands at a compelling juncture for investors seeking to explore opportunities in the healthcare information services sector. With a current market cap of $75.67 million,..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A Biotech Powerhouse with Nearly 100% Upside Potential

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company based in Boston, Massachusetts, is at the forefront of developing innovative therapies for central nervous system (CNS) disorders. With a..

ArriVent BioPharma, Inc. (AVBP): Analyst Ratings Suggest 45% Upside Potential for This Biotech Contender

ArriVent BioPharma, Inc. (AVBP), a clinical-stage biopharmaceutical company, is capturing investor attention with its potential for significant upside. With a robust focus on addressing unmet medical needs in cancer treatment,..

Xeris Biopharma Holdings (XERS) Stock Analysis: Promising 34% Upside Potential Amidst Robust Growth

Xeris Biopharma Holdings, Inc. (XERS), a dynamic player in the healthcare sector, is gaining traction among investors with its promising growth trajectory and compelling pipeline of innovative therapies. Headquartered in..

Savara, Inc. (SVRA) Investor Outlook: A Biotech Gem with Nearly 100% Upside Potential

For investors with a keen eye on the biotechnology sector, Savara, Inc. (NASDAQ: SVRA) presents an intriguing opportunity. This clinical-stage biopharmaceutical company, headquartered in Yardley, Pennsylvania, is primarily focused on..

Stoke Therapeutics, Inc. (STOK) Investor Outlook: Navigating the 52.52% Potential Upside in Biotech

Stoke Therapeutics, Inc. (NASDAQ: STOK), a burgeoning player in the biotechnology sector, presents a compelling opportunity for investors looking to tap into the healthcare industry’s innovative edge. With a market..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Unlocking Potential with a 640% Upside

Anavex Life Sciences Corp. (NASDAQ: AVXL) is drawing considerable attention from investors with its compelling promise in the biopharmaceutical sector, particularly given its potential upside of 640.74% as projected by..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Unveiling a Potential 238% Upside in Biotech

Bicycle Therapeutics plc (NASDAQ: BCYC) is making waves in the biotechnology sector with its innovative approach to disease treatment through the development of Bicycle toxin conjugates (BTCs). As a clinical-stage..

Delcath Systems, Inc. (DCTH) Stock Analysis: Exploring a Promising 79% Upside in Healthcare Innovation

For investors seeking opportunities in the burgeoning field of medical devices, Delcath Systems, Inc. (NASDAQ: DCTH) offers a compelling proposition. With a market capitalization of $415.64 million, Delcath is a..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Exploring a 19.95% Upside Potential

Amylyx Pharmaceuticals, Inc. (AMLX), a clinical-stage pharmaceutical company based in Cambridge, Massachusetts, is making waves in the healthcare sector. Specializing in the discovery and development of treatments for neurodegenerative diseases..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating a 39.66% Potential Downside Amid Healthcare Growth

InnovAge Holding Corp. (NASDAQ: INNV) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. The company is headquartered in Denver, Colorado, and focuses on..

InMode Ltd. (INMD) Stock Report: Navigating Growth in the Medical Devices Sector with a 1.58% Potential Upside

InMode Ltd. (NASDAQ: INMD) is carving out its niche in the healthcare sector, specifically within the medical devices industry. The company, headquartered in Yokne’am, Israel, has been making waves with..

Embecta Corp. (EMBC) Stock Analysis: Exploring a 12.6% Dividend Yield in a Challenging Healthcare Sector

Embecta Corp. (EMBC), a player in the healthcare sector specializing in medical instruments and supplies, has recently drawn investor attention with its unusually high dividend yield of 12.6%. For those..

Search

Funds

July 31, 2026

Search

Funds

July 31, 2026

FTSE 100

Funds